Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Capital Expenditures (2024 - 2025)

Carlsmed (CARL) has disclosed Capital Expenditures for 2 consecutive years, with -$528000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 343.7% year-over-year to -$528000.0, compared with a TTM value of -$436000.0 through Dec 2025, changed N/A, and an annual FY2025 reading of $41000.0, changed N/A over the prior year.
  • Capital Expenditures was -$528000.0 for Q4 2025 at Carlsmed, down from $159000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $159000.0 in Q3 2025 and bottomed at -$528000.0 in Q4 2025.